Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non–small-cell lung cancer

A Aupérin, C Le Péchoux, E Rolland… - Journal of clinical …, 2010 - ascopubs.org
Purpose The previous individual patient data meta-analyses of chemotherapy in locally
advanced non–small-cell lung cancer (NSCLC) showed that adding sequential or …

[PDF][PDF] American Society of Clinical Oncology treatment of unresectable non–small-cell lung cancer guideline: Update 2003

DG Pfister, DH Johnson, CG Azzoli… - Journal of Clinical …, 2004 - scholar.archive.org
The American Society of Clinical Oncology (ASCO) previously published evidencebased
guidelines for the treatment of unresectable non–small-cell lung cancer (NSCLC)[1]. ASCO …

PROCLAIM: randomized phase III trial of pemetrexed-cisplatin or etoposide-cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally …

S Senan, A Brade, L Wang, J Vansteenkiste… - Journal of clinical …, 2016 - ascopubs.org
Purpose The phase III PROCLAIM study evaluated overall survival (OS) of concurrent
pemetrexed-cisplatin and thoracic radiation therapy (TRT) followed by consolidation …

Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice …

GA Silvestri, AV Gonzalez, MA Jantz, ML Margolis… - Chest, 2013 - Elsevier
Background Correctly staging lung cancer is important because the treatment options and
prognosis differ significantly by stage. Several noninvasive imaging studies and invasive …

Delivering affordable cancer care in high-income countries

R Sullivan, J Peppercorn, K Sikora, J Zalcberg… - The lancet …, 2011 - thelancet.com
The burden of cancer is growing, and the disease is becoming a major economic
expenditure for all developed countries. In 2008, the worldwide cost of cancer due to …

Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines

GA Silvestri, MK Gould, ML Margolis, LT Tanoue… - Chest, 2007 - Elsevier
Background Correctly staging lung cancer is important because the treatment options and
the prognosis differ significantly by stage. Several noninvasive imaging studies including …

The evolving role of radiotherapy in non-small cell lung cancer

S Brown, K Banfill, MC Aznar… - The British journal of …, 2019 - academic.oup.com
Lung cancer is the most commonly diagnosed cancer and biggest cause of cancer mortality
worldwide with non-small cell lung cancer (NSCLC) accounting for most cases …

Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients …

MP Mac Manus, RJ Hicks, JP Matthews… - Journal of Clinical …, 2003 - ascopubs.org
Purpose: To prospectively study the capacity of positron emission tomography (PET) and
computed tomography (CT) to determine response soon after radical radiotherapy or …

Prediction of Survival by [18F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Locally Advanced Non–Small-Cell Lung Cancer Undergoing …

M Machtay, F Duan, BA Siegel, BS Snyder… - Journal of clinical …, 2013 - ascopubs.org
Purpose In this prospective National Cancer Institute–funded American College of
Radiology Imaging Network/Radiation Therapy Oncology Group cooperative group trial, we …

The noninvasive staging of non-small cell lung cancer: the guidelines

GA Silvestri, LT Tanoue, ML Margolis, J Barker… - Chest, 2003 - Elsevier
Correctly staging lung cancer is extremely important because the treatment options and the
prognosis differ significantly by stage. Several noninvasive imaging studies are available to …